---
$id: https://graph.org.ai/products/commodity/51143009
$type: Product
source: UNSPSC
code: "51143009"
title: "Dalfampridine or fampridine"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dalfampridine or fampridine

**UNSPSC Code**: 51143009
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker with the molecular formula C5H6N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BH3B64OKL9, chemically known as 4-pyridinamine, monohydrochloride but generally known as fampridine, which bears US NIH Compound Identifier 1727. European Medicines Agency schedules Fampridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07505MIG. The term FAMPRIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules fampridine in its Anatomical Therapeutic Chemical (ATC) Classification. Dalfampridine or fampridine bears US NLM identifiers UMLS ID C0000477 and NCI Concept Code C76777. SMILES: C1=CN=CC=C1N.

